SlideShare ist ein Scribd-Unternehmen logo
1 von 18
Data sharing in Canada through the COGR:
a unified clinical genome database as a community
resource for standardizing and sharing genetic
interpretations
Dr. Matthew Lebo, Kathleen-Rose Zakoor, Dr. Jordan Lerner-Ellis and
the Canadian Open Genetics Repository Working Group
Overview
• Grant funded by Genome Canada
• Collaborative effort for the collection, sharing
and analysis of variants reported by medical
diagnostic laboratories across Canada
• Collaborate with other global initiatives
including ClinVar, BRCA Challenge, Human
Variome Project
2
23 GeneInsight Instances Created
Organization Upload Status Sharing Status
Alberta Children's Hospital, Calgary AB Uploaded Sharing
Atlantic Cancer Research Institute, Moncton NB Pending -
British Columbia Cancer Agency, Vancouver BC Uploaded Sharing
Children’s & Women’s Health Centre of BC, Vancouver BC Uploading -
Children's Hospital of Eastern Ontario, Ottawa ON Uploaded Sharing*
Credit Valley Hospital, Trillium Health Centre, Mississauga ON Uploaded Sharing
Dept of Medical Genetics, University of Alberta, Edmonton AB Uploading -
Hamilton Health Sciences, McMaster University, Hamilton ON Uploaded -
Impact Genetics Inc., Bowmanville ON Pending -
Izaak Walton Killam Health Centre, Dalhousie University, Halifax NS Uploading -
Jewish General Hospital, Montréal QC Uploading
Kingston General Hospital, Queen’s University, Kingston ON Uploaded Sharing
McGill University Health Complex, Montréal QC Uploaded -
Memorial Health University Medical Center, St. John’s NL Pending -
Mount Sinai Hospital, University of Toronto, Toronto ON Uploaded Sharing*
North York General Hospital, Toronto ON Uploaded Sharing
Ontario Institute of Cancer Research (OICR), Toronto ON Uploaded Sharing
Regional Health Authority, University of Manitoba, Winnipeg MB Uploading Sharing
Sainte-Justine Hospital, University of Montreal, Montréal QC Uploading -
SickKids Hospital and McLaughlin Centre, Toronto ON Uploaded Sharing
University Hospital, Western University, London ON Pending -
Women's College Hospital, University of Toronto, Toronto ON Uploaded Sharing*
*Also sharing with VariantWire 3
COGR Variant Numbers
COGR Comparison 2014/2015
Variants
Copy Number
Variants
2014 3802 3339
2015 12607 4659
0
2000
4000
6000
8000
10000
12000
14000
4
• >17,000 variants
• 1,266 genes
• 66 diseases
Workflow Overview
5
The COGR Recent Initiative
• 2016 marks the COGR’s 4th year
– Focus to make data holdings both extremely
accurate and readily accessible
• Focus on creating and dispersing lab specific
discrepancy reports
– Build consensus clinical interpretations on variants
identified in Canadian diagnostic laboratories and
academic medical centers
– Initial project looked at BRCA1/2 6
7
COGR - BRCA Participating Institutions
8
A. Alberta Children’s Hospital (Calgary, AB)
B. Atlantic Cancer Research Institute (Moncton, NB)
C. British Columbia Cancer Agency (Vancouver BC)
D. Children’s & Women’s Health Centre of BC (Vancouver BC)
E. Children’s Hospital of Eastern Ontario (Ottawa ON)
F. Credit Valley Hospital, Trillium Health Centre (Mississauga ON)
G. Dept of Medical Genetics, University of Alberta (Edmonton, AB)
H. Hamilton Health Sciences, McMaster University (Hamilton, ON)
I. Impact Genetics Inc. (Bowmanville, ON)
J. Izaak Walton Killam Health Centre (Halifax, NS)
K. Kingston General Hospital, Queen’s University (Kingston, ON)
L. McGill University Health Complex (Montréal, QC)
M. Memorial Health University Medical Center (St. John’s, NL)
N. Mount Sinai Hospital, University of Toronto (Toronto, ON)
O. North York General Hospital (Toronto ON)
P. Ontario Institute of Cancer Research (OICR) (Toronto, ON)
Q. Regional Health Authority, University of Manitoba (Winnipeg, MB)
R. Sainte-Justine Hospital, University of Montreal (Montréal, QC)
S. SickKids Hospital and McLaughlin Centre (Toronto, ON)
T. University Hospital, Western University (London, ON)
U. Women’s College Hospital, University of Toronto (Toronto, ON)
V. Jewish General Hospital, Montreal (Montréal, QC)
COGR-BRCA Participant
COGR Participant
Discrepancy Report Results Overview
1. Overall discrepancy report results
2. Total changes in classifications and reasoning
3. Changes in discrepant variant classifications
4. Methods for reassessment
• 11 participating labs across 4 provinces
– ON, BC, AB, MB
• Received total of 5,554 BRCA1/2 variants
– 3014 unique variants
• 1,148 seen in >2 labs
– 110 to 1072 variants per lab (505 on average)
9
Submission Data - Before Issuing
Discrepancy Reports
After data submission 1,148 unique variants were
identified in more than one lab
• 550 (48%) of variants had concordant classifications
• 350 (30%) were discordant
• 248 (22%) were unclassified by all labs
*According to 5-tier classification system
10
Tiered Discrepancy Systems
5-tiered
- Initially implemented
3-tiered
- Recommended by
participants
2-tieried
- Clinical management
11
After Review of Discrepancy
Report Results
• 42% of discordant variants changed classifications
• 28% did not change classifications
• 30% were not reassessed
12
Initial Interpretations Final Interpretations
# Variants % # Variants % Overall Change
Benign 526 37% 637 45% 111 (8%)
Likely Benign 271 19% 321 23% 50 (4%)
VUS 342 24% 211 15% 127 (9%)
Likely Pathogenic 60 4% 64 5% 4 (>1%)
Pathogenic 136 10% 170 12% 34 (2%)
Unclassified 75 5% 9 1% 72 (5%)
Total 1410 1410 398 (28%)
After Review of Discrepancy
Report Results
• Only 18% of the discrepant variants reached a consensus for
5-tier system
– But most labs did not review minor discrepancies
• Benign vs Likely Benign
• Pathogenic vs Likely Pathogenic
• In total, for 5-tier system:
– 69% (622/900) of all unique & classified variants were concordant
• In total, for 3-tier system (LB/B, VUS, LP/P)
– 86% (770/900) of all unique & classified variants were concordant
13
Final Discrepancy Results
14
622
278
770
130
887
13
0
100
200
300
400
500
600
700
800
900
1000
Concordant Discrepant
NumberofUniqueVariants
5-Tier
3-Tier
2-Tier
Reasoning For Reclassification
15
• 9 out of 11 labs specified reasoning for some
variants
• 64% of reassessed variants provided reclassification
reasoning:
13%
37%42%
8% Typographical error
Based on new evidence provided
Revised classification criteria
Other (Please specify)
Methods Used for Reassessment
43%
45%
6%
6% We used our own methodology
or tools to reassess
We used the COGR variant
assessment tool (VAT)
We used the ACMG
reclassification tool provided
Other
16
• Most labs did not review variants through the COGR network
• 8 out of 11 labs specified their reassessment methods
• 34% of variants had specified reassessment methods:
Summary
• Successful exercise with positive feedback within the
COGR community
• Limited resources provide challenges for labs to do
this without guidance and help
• Continuing initiatives:
– Release quarterly discrepancy reports
– Provide consensus variant interpretations through public
database
– Further collaboration with other international data-sharing
efforts including ClinVar, the HVP and the GA4GH
17
opengenetics.ca
This work was funded by the Government of Canada through Genome Canada and
the Ontario Genomics Institute (OGI-070)
18

Weitere ähnliche Inhalte

Mehr von Human Variome Project

GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès RötigGENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
Human Variome Project
 
Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha KnoppersUse of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Human Variome Project
 
Checking the experts: compliance with author instructions regarding HGVS nome...
Checking the experts: compliance with author instructions regarding HGVS nome...Checking the experts: compliance with author instructions regarding HGVS nome...
Checking the experts: compliance with author instructions regarding HGVS nome...
Human Variome Project
 
Pathogenicity Decision Pathway in Tuberous Sclerosis Complex - Rosemary Ekong
Pathogenicity Decision Pathway in Tuberous Sclerosis Complex - Rosemary EkongPathogenicity Decision Pathway in Tuberous Sclerosis Complex - Rosemary Ekong
Pathogenicity Decision Pathway in Tuberous Sclerosis Complex - Rosemary Ekong
Human Variome Project
 
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...
Human Variome Project
 
Phenotype-based Matching Using PhenoDB Terms in BHCMG PhenoDB to Maximize Who...
Phenotype-based Matching Using PhenoDB Terms in BHCMG PhenoDB to Maximize Who...Phenotype-based Matching Using PhenoDB Terms in BHCMG PhenoDB to Maximize Who...
Phenotype-based Matching Using PhenoDB Terms in BHCMG PhenoDB to Maximize Who...
Human Variome Project
 
HIPBI-RD: Harmonising phenomics information for a better interoperability in ...
HIPBI-RD: Harmonising phenomics information for a better interoperability in ...HIPBI-RD: Harmonising phenomics information for a better interoperability in ...
HIPBI-RD: Harmonising phenomics information for a better interoperability in ...
Human Variome Project
 

Mehr von Human Variome Project (20)

HVP Country Node: Venezuela - Aida Falcon de Vargas
HVP Country Node: Venezuela - Aida Falcon de VargasHVP Country Node: Venezuela - Aida Falcon de Vargas
HVP Country Node: Venezuela - Aida Falcon de Vargas
 
Human Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent AbelHuman Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent Abel
 
HVP Country Node: Malaysia - Zilfalil bin Alwi
HVP Country Node: Malaysia - Zilfalil bin AlwiHVP Country Node: Malaysia - Zilfalil bin Alwi
HVP Country Node: Malaysia - Zilfalil bin Alwi
 
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès RötigGENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
 
The BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
The BRCA Challenge & Exchange: Progress and Plans - Gunnar RätschThe BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
The BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
 
Richard GH Cotton: He may have been a bit before his time - Michael Watson
Richard GH Cotton: He may have been a bit before his time - Michael WatsonRichard GH Cotton: He may have been a bit before his time - Michael Watson
Richard GH Cotton: He may have been a bit before his time - Michael Watson
 
Professor Richard Cotton - Finlay Macrae
Professor Richard Cotton - Finlay MacraeProfessor Richard Cotton - Finlay Macrae
Professor Richard Cotton - Finlay Macrae
 
HVP Country Node: Canada - Matthew Lebo
HVP Country Node: Canada - Matthew LeboHVP Country Node: Canada - Matthew Lebo
HVP Country Node: Canada - Matthew Lebo
 
Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha KnoppersUse of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
 
HVP6: Final Thoughts - John Burn & Raj Ramesar
HVP6: Final Thoughts - John Burn & Raj RamesarHVP6: Final Thoughts - John Burn & Raj Ramesar
HVP6: Final Thoughts - John Burn & Raj Ramesar
 
Report from the International Scientific Advisory Committee - John Burn
Report from the International Scientific Advisory Committee - John BurnReport from the International Scientific Advisory Committee - John Burn
Report from the International Scientific Advisory Committee - John Burn
 
HVP Country Node: Italy - Domenico Coviello
HVP Country Node: Italy - Domenico CovielloHVP Country Node: Italy - Domenico Coviello
HVP Country Node: Italy - Domenico Coviello
 
Rare and common variants contribute to the complex inheritance of Hirschsprun...
Rare and common variants contribute to the complex inheritance of Hirschsprun...Rare and common variants contribute to the complex inheritance of Hirschsprun...
Rare and common variants contribute to the complex inheritance of Hirschsprun...
 
Report from the Gene & Disease Specific Database Advisory Council - Peter Ta...
Report from the  Gene & Disease Specific Database Advisory Council - Peter Ta...Report from the  Gene & Disease Specific Database Advisory Council - Peter Ta...
Report from the Gene & Disease Specific Database Advisory Council - Peter Ta...
 
Checking the experts: compliance with author instructions regarding HGVS nome...
Checking the experts: compliance with author instructions regarding HGVS nome...Checking the experts: compliance with author instructions regarding HGVS nome...
Checking the experts: compliance with author instructions regarding HGVS nome...
 
Pathogenicity Decision Pathway in Tuberous Sclerosis Complex - Rosemary Ekong
Pathogenicity Decision Pathway in Tuberous Sclerosis Complex - Rosemary EkongPathogenicity Decision Pathway in Tuberous Sclerosis Complex - Rosemary Ekong
Pathogenicity Decision Pathway in Tuberous Sclerosis Complex - Rosemary Ekong
 
HVP Country Node: The Netherlands - Marielle van Gijn
HVP Country Node: The Netherlands - Marielle van GijnHVP Country Node: The Netherlands - Marielle van Gijn
HVP Country Node: The Netherlands - Marielle van Gijn
 
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...
 
Phenotype-based Matching Using PhenoDB Terms in BHCMG PhenoDB to Maximize Who...
Phenotype-based Matching Using PhenoDB Terms in BHCMG PhenoDB to Maximize Who...Phenotype-based Matching Using PhenoDB Terms in BHCMG PhenoDB to Maximize Who...
Phenotype-based Matching Using PhenoDB Terms in BHCMG PhenoDB to Maximize Who...
 
HIPBI-RD: Harmonising phenomics information for a better interoperability in ...
HIPBI-RD: Harmonising phenomics information for a better interoperability in ...HIPBI-RD: Harmonising phenomics information for a better interoperability in ...
HIPBI-RD: Harmonising phenomics information for a better interoperability in ...
 

Kürzlich hochgeladen

Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Sérgio Sacani
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
MohamedFarag457087
 
Bacterial Identification and Classifications
Bacterial Identification and ClassificationsBacterial Identification and Classifications
Bacterial Identification and Classifications
Areesha Ahmad
 
The Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxThe Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptx
seri bangash
 

Kürzlich hochgeladen (20)

Zoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdfZoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdf
 
Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...
Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...
Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)
 
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort ServiceCall Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
 
Clean In Place(CIP).pptx .
Clean In Place(CIP).pptx                 .Clean In Place(CIP).pptx                 .
Clean In Place(CIP).pptx .
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
 
Forensic Biology & Its biological significance.pdf
Forensic Biology & Its biological significance.pdfForensic Biology & Its biological significance.pdf
Forensic Biology & Its biological significance.pdf
 
Bacterial Identification and Classifications
Bacterial Identification and ClassificationsBacterial Identification and Classifications
Bacterial Identification and Classifications
 
Factory Acceptance Test( FAT).pptx .
Factory Acceptance Test( FAT).pptx       .Factory Acceptance Test( FAT).pptx       .
Factory Acceptance Test( FAT).pptx .
 
COST ESTIMATION FOR A RESEARCH PROJECT.pptx
COST ESTIMATION FOR A RESEARCH PROJECT.pptxCOST ESTIMATION FOR A RESEARCH PROJECT.pptx
COST ESTIMATION FOR A RESEARCH PROJECT.pptx
 
Sector 62, Noida Call girls :8448380779 Model Escorts | 100% verified
Sector 62, Noida Call girls :8448380779 Model Escorts | 100% verifiedSector 62, Noida Call girls :8448380779 Model Escorts | 100% verified
Sector 62, Noida Call girls :8448380779 Model Escorts | 100% verified
 
Dubai Call Girls Beauty Face Teen O525547819 Call Girls Dubai Young
Dubai Call Girls Beauty Face Teen O525547819 Call Girls Dubai YoungDubai Call Girls Beauty Face Teen O525547819 Call Girls Dubai Young
Dubai Call Girls Beauty Face Teen O525547819 Call Girls Dubai Young
 
300003-World Science Day For Peace And Development.pptx
300003-World Science Day For Peace And Development.pptx300003-World Science Day For Peace And Development.pptx
300003-World Science Day For Peace And Development.pptx
 
Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.
 
The Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxThe Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptx
 
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 60009654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
 
GBSN - Biochemistry (Unit 1)
GBSN - Biochemistry (Unit 1)GBSN - Biochemistry (Unit 1)
GBSN - Biochemistry (Unit 1)
 
chemical bonding Essentials of Physical Chemistry2.pdf
chemical bonding Essentials of Physical Chemistry2.pdfchemical bonding Essentials of Physical Chemistry2.pdf
chemical bonding Essentials of Physical Chemistry2.pdf
 
9999266834 Call Girls In Noida Sector 22 (Delhi) Call Girl Service
9999266834 Call Girls In Noida Sector 22 (Delhi) Call Girl Service9999266834 Call Girls In Noida Sector 22 (Delhi) Call Girl Service
9999266834 Call Girls In Noida Sector 22 (Delhi) Call Girl Service
 

Data sharing in Canada through the Canadian Open Genetics Repository (COGR): a unified clinical genome database as a community resource for standardizing and sharing genetic interpretations Matthew Lebo

  • 1. Data sharing in Canada through the COGR: a unified clinical genome database as a community resource for standardizing and sharing genetic interpretations Dr. Matthew Lebo, Kathleen-Rose Zakoor, Dr. Jordan Lerner-Ellis and the Canadian Open Genetics Repository Working Group
  • 2. Overview • Grant funded by Genome Canada • Collaborative effort for the collection, sharing and analysis of variants reported by medical diagnostic laboratories across Canada • Collaborate with other global initiatives including ClinVar, BRCA Challenge, Human Variome Project 2
  • 3. 23 GeneInsight Instances Created Organization Upload Status Sharing Status Alberta Children's Hospital, Calgary AB Uploaded Sharing Atlantic Cancer Research Institute, Moncton NB Pending - British Columbia Cancer Agency, Vancouver BC Uploaded Sharing Children’s & Women’s Health Centre of BC, Vancouver BC Uploading - Children's Hospital of Eastern Ontario, Ottawa ON Uploaded Sharing* Credit Valley Hospital, Trillium Health Centre, Mississauga ON Uploaded Sharing Dept of Medical Genetics, University of Alberta, Edmonton AB Uploading - Hamilton Health Sciences, McMaster University, Hamilton ON Uploaded - Impact Genetics Inc., Bowmanville ON Pending - Izaak Walton Killam Health Centre, Dalhousie University, Halifax NS Uploading - Jewish General Hospital, Montréal QC Uploading Kingston General Hospital, Queen’s University, Kingston ON Uploaded Sharing McGill University Health Complex, Montréal QC Uploaded - Memorial Health University Medical Center, St. John’s NL Pending - Mount Sinai Hospital, University of Toronto, Toronto ON Uploaded Sharing* North York General Hospital, Toronto ON Uploaded Sharing Ontario Institute of Cancer Research (OICR), Toronto ON Uploaded Sharing Regional Health Authority, University of Manitoba, Winnipeg MB Uploading Sharing Sainte-Justine Hospital, University of Montreal, Montréal QC Uploading - SickKids Hospital and McLaughlin Centre, Toronto ON Uploaded Sharing University Hospital, Western University, London ON Pending - Women's College Hospital, University of Toronto, Toronto ON Uploaded Sharing* *Also sharing with VariantWire 3
  • 4. COGR Variant Numbers COGR Comparison 2014/2015 Variants Copy Number Variants 2014 3802 3339 2015 12607 4659 0 2000 4000 6000 8000 10000 12000 14000 4 • >17,000 variants • 1,266 genes • 66 diseases
  • 6. The COGR Recent Initiative • 2016 marks the COGR’s 4th year – Focus to make data holdings both extremely accurate and readily accessible • Focus on creating and dispersing lab specific discrepancy reports – Build consensus clinical interpretations on variants identified in Canadian diagnostic laboratories and academic medical centers – Initial project looked at BRCA1/2 6
  • 7. 7
  • 8. COGR - BRCA Participating Institutions 8 A. Alberta Children’s Hospital (Calgary, AB) B. Atlantic Cancer Research Institute (Moncton, NB) C. British Columbia Cancer Agency (Vancouver BC) D. Children’s & Women’s Health Centre of BC (Vancouver BC) E. Children’s Hospital of Eastern Ontario (Ottawa ON) F. Credit Valley Hospital, Trillium Health Centre (Mississauga ON) G. Dept of Medical Genetics, University of Alberta (Edmonton, AB) H. Hamilton Health Sciences, McMaster University (Hamilton, ON) I. Impact Genetics Inc. (Bowmanville, ON) J. Izaak Walton Killam Health Centre (Halifax, NS) K. Kingston General Hospital, Queen’s University (Kingston, ON) L. McGill University Health Complex (Montréal, QC) M. Memorial Health University Medical Center (St. John’s, NL) N. Mount Sinai Hospital, University of Toronto (Toronto, ON) O. North York General Hospital (Toronto ON) P. Ontario Institute of Cancer Research (OICR) (Toronto, ON) Q. Regional Health Authority, University of Manitoba (Winnipeg, MB) R. Sainte-Justine Hospital, University of Montreal (Montréal, QC) S. SickKids Hospital and McLaughlin Centre (Toronto, ON) T. University Hospital, Western University (London, ON) U. Women’s College Hospital, University of Toronto (Toronto, ON) V. Jewish General Hospital, Montreal (Montréal, QC) COGR-BRCA Participant COGR Participant
  • 9. Discrepancy Report Results Overview 1. Overall discrepancy report results 2. Total changes in classifications and reasoning 3. Changes in discrepant variant classifications 4. Methods for reassessment • 11 participating labs across 4 provinces – ON, BC, AB, MB • Received total of 5,554 BRCA1/2 variants – 3014 unique variants • 1,148 seen in >2 labs – 110 to 1072 variants per lab (505 on average) 9
  • 10. Submission Data - Before Issuing Discrepancy Reports After data submission 1,148 unique variants were identified in more than one lab • 550 (48%) of variants had concordant classifications • 350 (30%) were discordant • 248 (22%) were unclassified by all labs *According to 5-tier classification system 10
  • 11. Tiered Discrepancy Systems 5-tiered - Initially implemented 3-tiered - Recommended by participants 2-tieried - Clinical management 11
  • 12. After Review of Discrepancy Report Results • 42% of discordant variants changed classifications • 28% did not change classifications • 30% were not reassessed 12 Initial Interpretations Final Interpretations # Variants % # Variants % Overall Change Benign 526 37% 637 45% 111 (8%) Likely Benign 271 19% 321 23% 50 (4%) VUS 342 24% 211 15% 127 (9%) Likely Pathogenic 60 4% 64 5% 4 (>1%) Pathogenic 136 10% 170 12% 34 (2%) Unclassified 75 5% 9 1% 72 (5%) Total 1410 1410 398 (28%)
  • 13. After Review of Discrepancy Report Results • Only 18% of the discrepant variants reached a consensus for 5-tier system – But most labs did not review minor discrepancies • Benign vs Likely Benign • Pathogenic vs Likely Pathogenic • In total, for 5-tier system: – 69% (622/900) of all unique & classified variants were concordant • In total, for 3-tier system (LB/B, VUS, LP/P) – 86% (770/900) of all unique & classified variants were concordant 13
  • 15. Reasoning For Reclassification 15 • 9 out of 11 labs specified reasoning for some variants • 64% of reassessed variants provided reclassification reasoning: 13% 37%42% 8% Typographical error Based on new evidence provided Revised classification criteria Other (Please specify)
  • 16. Methods Used for Reassessment 43% 45% 6% 6% We used our own methodology or tools to reassess We used the COGR variant assessment tool (VAT) We used the ACMG reclassification tool provided Other 16 • Most labs did not review variants through the COGR network • 8 out of 11 labs specified their reassessment methods • 34% of variants had specified reassessment methods:
  • 17. Summary • Successful exercise with positive feedback within the COGR community • Limited resources provide challenges for labs to do this without guidance and help • Continuing initiatives: – Release quarterly discrepancy reports – Provide consensus variant interpretations through public database – Further collaboration with other international data-sharing efforts including ClinVar, the HVP and the GA4GH 17
  • 18. opengenetics.ca This work was funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-070) 18

Hinweis der Redaktion

  1. As of December 15th 2015 over 17,000 variants on the system across approximately 90 genes and 60 diseases;